385 related articles for article (PubMed ID: 27030269)
1. Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.
Alfadhli A; Mack A; Ritchie C; Cylinder I; Harper L; Tedbury PR; Freed EO; Barklis E
J Virol; 2016 Jun; 90(12):5657-5664. PubMed ID: 27030269
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
3. Analysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions.
Alfadhli A; Staubus AO; Tedbury PR; Novikova M; Freed EO; Barklis E
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375589
[TBL] [Abstract][Full Text] [Related]
4. Biochemical evidence of a role for matrix trimerization in HIV-1 envelope glycoprotein incorporation.
Tedbury PR; Novikova M; Ablan SD; Freed EO
Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E182-90. PubMed ID: 26711999
[TBL] [Abstract][Full Text] [Related]
5. Second site reversion of HIV-1 envelope protein baseplate mutations maps to the matrix protein.
Alfadhli A; Romanaggi C; Barklis RL; Barklis E
J Virol; 2024 Feb; 98(2):e0174223. PubMed ID: 38193694
[TBL] [Abstract][Full Text] [Related]
6. Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.
Tedbury PR; Mercredi PY; Gaines CR; Summers MF; Freed EO
J Mol Biol; 2015 Mar; 427(6 Pt B):1413-1427. PubMed ID: 25659909
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of HIV-1 matrix mutants implicated in envelope incorporation.
Eastep GN; Ghanam RH; Green TJ; Saad JS
J Biol Chem; 2021; 296():100321. PubMed ID: 33485964
[TBL] [Abstract][Full Text] [Related]
8. The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation.
Murphy RE; Saad JS
Viruses; 2020 May; 12(5):. PubMed ID: 32429351
[TBL] [Abstract][Full Text] [Related]
9. HIV cell-to-cell transmission requires the production of infectious virus particles and does not proceed through env-mediated fusion pores.
Monel B; Beaumont E; Vendrame D; Schwartz O; Brand D; Mammano F
J Virol; 2012 Apr; 86(7):3924-33. PubMed ID: 22258237
[TBL] [Abstract][Full Text] [Related]
10. Single-molecule imaging of HIV-1 envelope glycoprotein dynamics and Gag lattice association exposes determinants responsible for virus incorporation.
Pezeshkian N; Groves NS; van Engelenburg SB
Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25269-25277. PubMed ID: 31757854
[TBL] [Abstract][Full Text] [Related]
11. Replication of HIV-1 envelope protein cytoplasmic domain variants in permissive and restrictive cells.
Staubus AO; Alfadhli A; Barklis RL; Barklis E
Virology; 2019 Dec; 538():1-10. PubMed ID: 31550607
[TBL] [Abstract][Full Text] [Related]
12. Global rescue of defects in HIV-1 envelope glycoprotein incorporation: implications for matrix structure.
Tedbury PR; Ablan SD; Freed EO
PLoS Pathog; 2013; 9(11):e1003739. PubMed ID: 24244165
[TBL] [Abstract][Full Text] [Related]
13. A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles.
Brandano L; Stevenson M
J Virol; 2012 Feb; 86(4):2347-59. PubMed ID: 22156517
[TBL] [Abstract][Full Text] [Related]
14. The role of matrix in HIV-1 envelope glycoprotein incorporation.
Tedbury PR; Freed EO
Trends Microbiol; 2014 Jul; 22(7):372-8. PubMed ID: 24933691
[TBL] [Abstract][Full Text] [Related]
15. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.
Mammano F; Kondo E; Sodroski J; Bukovsky A; Göttlinger HG
J Virol; 1995 Jun; 69(6):3824-30. PubMed ID: 7745730
[TBL] [Abstract][Full Text] [Related]
16. Relationships between MA-RNA Binding in Cells and Suppression of HIV-1 Gag Mislocalization to Intracellular Membranes.
Thornhill D; Olety B; Ono A
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511376
[TBL] [Abstract][Full Text] [Related]
17. Characterization of replication defects induced by mutations in the basic domain and C-terminus of HIV-1 matrix.
Bhatia AK; Campbell N; Panganiban A; Ratner L
Virology; 2007 Dec; 369(1):47-54. PubMed ID: 17706261
[TBL] [Abstract][Full Text] [Related]
18. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
Freed EO; Martin MA
J Virol; 1996 Jan; 70(1):341-51. PubMed ID: 8523546
[TBL] [Abstract][Full Text] [Related]
19. Maturation of the matrix and viral membrane of HIV-1.
Qu K; Ke Z; Zila V; Anders-Össwein M; Glass B; Mücksch F; Müller R; Schultz C; Müller B; Kräusslich HG; Briggs JAG
Science; 2021 Aug; 373(6555):700-704. PubMed ID: 34353956
[TBL] [Abstract][Full Text] [Related]
20. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail.
Murakami T; Freed EO
J Virol; 2000 Apr; 74(8):3548-54. PubMed ID: 10729129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
